+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID07135882

Randomized Trial of Radiotherapy Plus Standard Therapy for Advanced Non-Small Cell Lung Cancer

Led by Trans Tasman Radiation Oncology Group · Updated on 2026-10-23

420

Participants Needed

6

Research Sites

313 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating metastatic non-small cell lung cancer NSCLC, a leading cause of cancer death with limited survival despite current drug therapies. This study evaluates whether adding radiotherapy to the primary lung tumor alongside standard drug treatment can reduce cancer spread, improve survival, enhance quality of life, and be cost-effective. The trial is a phase III randomized controlled study involving multiple expert teams and patient input, aiming to provide definitive answers for this critical medical need. Participants will receive either standard systemic chemotherapy alone or combined with highly precise radiotherapy targeting the primary lung tumor. Radiotherapy approaches include advanced techniques such as IMRT or VMAT, with several dosing schedules allowed, including 50Gy in 20 fractions, 40Gy in 15 fractions, or 35Gy in 5 fractions. The study leverages existing lung cancer registries across multiple sites to facilitate access and rapid adoption if successful. During the trial, participants will be monitored over several years with evaluations including overall survival up to five years post-recruitment, thoracic toxicity assessments, progression-free and cancer-specific survival, quality of life questionnaires, and economic analyses. Follow-up involves regular clinical assessments aligned with the study timeline to track treatment effects and safety. The total study duration extends to the end of 2036, providing comprehensive long-term data on outcomes and tolerability.

CONDITIONS

Brief Title

Primary Radiotherapy In MEtastatic Lung Cancer

Research Team

P

PRIME-Lung CRA

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here